Cheongju-si, South Korea

Hyun Soo Ju


 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyun Soo Ju: Innovator in Anti-Inflammatory Peptides

Introduction

Hyun Soo Ju is a notable inventor based in Cheongju-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel peptides with anti-inflammatory properties. His work has the potential to impact various health-related applications.

Latest Patents

Hyun Soo Ju holds a patent for "Peptides and use thereof." This invention focuses on novel peptides that exhibit anti-inflammatory effects. The patent encompasses a polynucleotide encoding the peptide, a pharmaceutical composition for preventing or treating inflammatory diseases, and various applications including over-the-counter drug compositions, health food compositions, and cosmetic formulations aimed at alleviating inflammation. The methods outlined in the patent also include treatment protocols for inflammatory diseases and techniques for preparing peptide mimetics.

Career Highlights

Throughout his career, Hyun Soo Ju has worked with prominent organizations such as the Samsung Life Public Welfare Foundation and Il-yang Pharm. Co., Ltd. His experience in these companies has allowed him to refine his expertise in pharmaceutical innovations and contribute to advancements in health science.

Collaborations

Hyun Soo Ju has collaborated with notable colleagues, including Dae Ho Cho and Min Kyung Jung. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Hyun Soo Ju's work in developing anti-inflammatory peptides showcases his commitment to advancing medical science. His patent and career achievements reflect his significant contributions to the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…